From Which VCs Are Poised to Profit From the Biotech IPO Boom?:

Beth Seidenberg of Kleiner Perkins Caufield & Byers

Beth Seidenberg of Kleiner Perkins Caufield & Byers—

Beth Seidenberg of Kleiner Perkins Caufield & Byers

Underwriters and Partners

Xconomy Insight

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Sponsored · Whitepaper
What to Include in Your Life Sciences Company Fundraising Pitch Deck
What the most successful life sciences fundraising pitch decks all have in common
Brex

From Our Editors · Podcast
Xcelerating Life Sciences Philadelphia: The Highlights Podcast
Becoming the Cell & Gene Therapy Hub

Xconomy on Demand

We offer a number of ways to subscribe for free!